Article Text

Download PDFPDF
Clarithromycin-induced myoclonic status epilepticus
  1. Mahmut Sami Biçimveren
  1. Neurology, Uşak Training and Research Hospital, Uşak, Turkey
  1. Correspondence to Dr. Mahmut Sami Biçimveren; bcmvrnsami{at}gmail.com

Abstract

Myoclonus is a sudden brief involuntary activity and is either epileptic or non-epileptic. Myoclonic seizures are common in juvenile myoclonic epilepsy and in the much rarer childhood epilepsies, such as Dravet syndrome and Doose syndrome. However, they also occur at any age in adults. Myoclonic seizures may occur in cortical stroke, Alzheimer’s disease, Lance-Adams syndrome, autoimmune limbic encephalitis and toxic-metabolic disorders. Clarithromycin may also cause myoclonic status epilepticus. We report a patient with myoclonic status epilepticus induced by clarithromycin.

  • MYOCLONUS
  • EPILEPSY

Data availability statement

No data are available. Written informed consent was obtained from the patient for the use of the data.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

No data are available. Written informed consent was obtained from the patient for the use of the data.

View Full Text

Footnotes

  • Contributors Sole author, assessment of the patient, interpretation of the EEG, video recording, preparation of the manuscript, review of the literature were performed by MSB.

  • Funding The author has not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned. Externally peer reviewed by Udo Weishmann, London, UK.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.